Institute of Hepatobiliary Surgery, First Affiliated Hospital, Army Medical University, Chongqing, China.
The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.
J Hepatobiliary Pancreat Sci. 2022 Jun;29(6):629-640. doi: 10.1002/jhbp.1129. Epub 2022 Mar 10.
BACKGROUND/PURPOSE: This over 7-year case study is the first to compare the results of laparoscopic Glissonian pedicle approach hemihepatectomy (LGAH) and laparoscopic hilar dissection approach hemihepatectomy (LHAH) in a randomized controlled trial (RCT).
Patients who had undergone laparoscopic hemihepatectomy, either LGAH or LHAH, between March 2012 and December 2019 at our center were prospectively enrolled and assigned to the LGAH or LHAH group. Both groups were stratified and compared, and the preoperative and follow-up outcomes were analyzed. The primary endpoint was total operative time.
The groups were equally matched for age, sex, HBsAg, Child-Pugh class, benign disease, malignancy, liver cirrhosis, tumor diameter and type of resection. Ninety-six patients had undergone LGAH and 94 had undergone LHAH. No preoperative death occurred in the two groups. LGAH did not enhance the postoperative overall complication rates (P = .465) or intraoperative blood loss (P = .535) compared with LHAH. However, the overall operative time (P = .014) and hilar dissection time (P = .000) were significantly shorter in the LGAH group than in the LHAH group. No significant differences were found between the groups regarding the 1-year (P = .384), 3-year (P = .332), and 5-year overall survival rates (P = .662) or 1-year (P = .856), 3-year (P = .348), and 5-year disease-free survival rates (P = .573).
LGAH and LHAH are both effective procedures for treating the hilar structures in selected patients. LGAH has advantages over LHAH in reducing total operation time under the condition where both procedures can be used. LGAH for selected patients is worthy of promotion owing to its simplicity and convenience.
NCT01567631 (http://www.
gov).
背景/目的:本超过 7 年的病例研究首次在随机对照试验(RCT)中比较腹腔镜 Glisson 蒂入路半肝切除术(LGAH)和腹腔镜肝门部解剖入路半肝切除术(LHAH)的结果。
2012 年 3 月至 2019 年 12 月,前瞻性纳入在我院接受腹腔镜半肝切除术的患者,分为 LGAH 或 LHAH 组。对两组进行分层比较,分析术前和随访结果。主要终点是总手术时间。
两组在年龄、性别、HBsAg、Child-Pugh 分级、良性疾病、恶性肿瘤、肝硬化、肿瘤直径和切除类型方面匹配良好。96 例患者行 LGAH,94 例行 LHAH。两组均无术前死亡。与 LHAH 相比,LGAH 并未增加术后总体并发症发生率(P=0.465)或术中出血量(P=0.535)。然而,LGAH 组的总手术时间(P=0.014)和肝门部解剖时间(P=0.000)明显短于 LHAH 组。两组 1 年(P=0.384)、3 年(P=0.332)和 5 年总生存率(P=0.662)或 1 年(P=0.856)、3 年(P=0.348)和 5 年无病生存率(P=0.573)无显著差异。
在选择的患者中,LGAH 和 LHAH 都是治疗肝门结构的有效方法。在两种方法都可使用的情况下,LGAH 在缩短总手术时间方面优于 LHAH。对于选择的患者,LGAH 因其简单方便,值得推广。
NCT01567631(http://www.clinicaltrials.gov)。